103 related articles for article (PubMed ID: 23576199)
1. [Diagnostic and predictive analyses of cytological specimens of non-small cell lung cancer: strategies and challenges].
Herth FJ; Bubendorf L; Gütz S; Morresi-Hauf A; Hummel M; Junker K; Lehmann U; Petersen I; Schnabel PA; Warth A
Pneumologie; 2013 Apr; 67(4):198-204. PubMed ID: 23576199
[TBL] [Abstract][Full Text] [Related]
2. Tissue sampling in lung cancer: a review in light of the MERIT experience.
Reck M; Hermes A; Tan EH; Felip E; Klughammer B; Baselga J
Lung Cancer; 2011 Oct; 74(1):1-6. PubMed ID: 21658788
[TBL] [Abstract][Full Text] [Related]
3. Detection of EML4-ALK fusion genes in a few cancer cells from transbronchial cytological specimens utilizing immediate cytology during bronchoscopy.
Kanaji N; Bandoh S; Ishii T; Tadokoro A; Watanabe N; Takahama T; Haba R; Imataki O; Dobashi H; Matsunaga T
Lung Cancer; 2012 Aug; 77(2):293-8. PubMed ID: 22494566
[TBL] [Abstract][Full Text] [Related]
4. The tissue is the issue: personalized medicine for non-small cell lung cancer.
Hirsch FR; Wynes MW; Gandara DR; Bunn PA
Clin Cancer Res; 2010 Oct; 16(20):4909-11. PubMed ID: 20926402
[TBL] [Abstract][Full Text] [Related]
5. The future of oncology treatment through diagnostic testing.
Oakley G
MLO Med Lab Obs; 2013 Dec; 45(12):38. PubMed ID: 24409595
[No Abstract] [Full Text] [Related]
6. First-line therapy of mutated non-small cell lung cancer: an update.
Stöhlmacher-Williams J
Onkologie; 2012; 35(5):293-9. PubMed ID: 22868512
[TBL] [Abstract][Full Text] [Related]
7. Role of the pulmonologist in ordering post-procedure molecular markers in non-small-cell lung cancer: implications for personalized medicine.
Murgu S; Colt H
Clin Lung Cancer; 2013 Nov; 14(6):609-26. PubMed ID: 24188629
[TBL] [Abstract][Full Text] [Related]
8. [Molecular pathological diagnosis in cytopathology of non-small-cell lung cancer. Standardization of specimen processing].
Warth A; Bubendorf L; Gütz S; Morresi-Hauf A; Hummel M; Junker K; Lehmann U; Petersen I; Schnabel PA
Pathologe; 2013 Jul; 34(4):310-7. PubMed ID: 23728235
[TBL] [Abstract][Full Text] [Related]
9. Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing?
Kim L; Tsao MS
Eur Respir J; 2014 Oct; 44(4):1011-22. PubMed ID: 25102961
[TBL] [Abstract][Full Text] [Related]
10. The surgeon's role in molecular biology.
Rocco G
J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S18-22. PubMed ID: 22739075
[TBL] [Abstract][Full Text] [Related]
11. Establishing an EGFR mutation screening service for non-small cell lung cancer - sample quality criteria and candidate histological predictors.
Leary AF; Castro DG; Nicholson AG; Ashley S; Wotherspoon A; O'Brien ME; Popat S
Eur J Cancer; 2012 Jan; 48(1):61-7. PubMed ID: 22036089
[TBL] [Abstract][Full Text] [Related]
12. [New biomolecular methodologies in diagnosis of lung cancer].
Carpagnano GE; Palladino GP; Gramiccioni C; Spanevello A; Cagnazzo MG; Barbaro MP
Recenti Prog Med; 2008 Sep; 99(9):417-21. PubMed ID: 19044249
[TBL] [Abstract][Full Text] [Related]
13. "Personalizing" therapy for non-small cell lung cancer.
D'Cunha J
Semin Thorac Cardiovasc Surg; 2010; 22(2):118-20. PubMed ID: 21092888
[TBL] [Abstract][Full Text] [Related]
14. Personalized medicine for non-small-cell lung cancer: implications of recent advances in tissue acquisition for molecular and histologic testing.
Moreira AL; Thornton RH
Clin Lung Cancer; 2012 Sep; 13(5):334-9. PubMed ID: 22424871
[TBL] [Abstract][Full Text] [Related]
15. Individualized therapy for patients with non-small cell lung cancer: emerging trends and challenges.
Langer CJ
Crit Rev Oncol Hematol; 2012 Jul; 83(1):130-44. PubMed ID: 22280915
[TBL] [Abstract][Full Text] [Related]
16. Current and future molecular diagnostics in non-small-cell lung cancer.
Li CM; Chu WY; Wong DL; Tsang HF; Tsui NB; Chan CM; Xue VW; Siu PM; Yung BY; Chan LW; Wong SC
Expert Rev Mol Diagn; 2015; 15(8):1061-74. PubMed ID: 26153330
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathology of non-small cell lung cancer: a practical guide.
Aisner DL; Marshall CB
Am J Clin Pathol; 2012 Sep; 138(3):332-46. PubMed ID: 22912349
[TBL] [Abstract][Full Text] [Related]
18. Personalized medicine for lung cancer: new challenges for pathology.
Kerr KM
Histopathology; 2012 Mar; 60(4):531-46. PubMed ID: 21916947
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and predictive molecular analysis of non-small-cell lung cancer in the Africa-Middle East region: challenges and strategies for improvement.
Slavik T; Asselah F; Fakhruddin N; El Khodary A; Torjman F; Anis E; Quinn M; Khankan A; Kerr KM
Clin Lung Cancer; 2014 Nov; 15(6):398-404. PubMed ID: 25043210
[TBL] [Abstract][Full Text] [Related]
20. A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments.
Rossi G; Pelosi G; Graziano P; Barbareschi M; Papotti M
Int J Surg Pathol; 2009 Jun; 17(3):206-18. PubMed ID: 19443885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
